Join

Compare · BTI vs PRDS

BTI vs PRDS

Side-by-side comparison of British American Tobacco Industries p.l.c. (BTI) and Pardes Biosciences Inc. (PRDS): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both BTI and PRDS operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
  • BTI is the larger of the two at $133.92B, about 203.7x PRDS ($657.5M).
  • BTI has hit the wire 8 times in the past 4 weeks while PRDS has been quiet.
  • BTI has more recent analyst coverage (14 ratings vs 3 for PRDS).
MetricBTIPRDS
Company
British American Tobacco Industries p.l.c.
Pardes Biosciences Inc.
Price
$61.37+0.52%
$2.19+1.39%
Market cap
$133.92B
$657.5M
1M return
-5.68%
-
1Y return
+25.81%
-
Industry
Medicinal Chemicals and Botanical Products
Medicinal Chemicals and Botanical Products
Exchange
NYSE
NASDAQ
IPO
1998
2021
News (4w)
8
0
Recent ratings
14
3
BTI

British American Tobacco Industries p.l.c.

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers worldwide. It offers vapour products, tobacco heating products, and modern oral products; combustible products; and traditional oral products, such as Swedish-style snus and American moist snuff. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

PRDS

Pardes Biosciences Inc.

Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome coronavirus 2 infections and associated diseases. The company was incorporated in 2020 and is headquartered in Carlsbad, California.